Miłosz Andrzej Zajączkowski

Miłosz Andrzej Zajączkowski

Auto-generated profile, based on publicly available information

Miłosz Andrzej Zajączkowski

Division of Clinical Anatomy, Department of Anatomy, Faculty of Medicine, Medical University of Gdansk, Dębinki 1, 80-211 Gdańsk, Poland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JMJoanna Miklosz
Joanna Miklosz
BKBartlomiej Kalaska
Bartlomiej Kalaska
PPPiotr Podlasz
Piotr Podlasz
MCMałgorzata Chmielewska-Krzesińska
Małgorzata Chmielewska-Krzesińska
MZMiłosz Zajączkowski
Miłosz Zajączkowski
Andrzej MogielnickiAndrzej Mogielnicki
Andrzej Mogielnicki
Protamine sulfate (PS) is the only available option to reverse the anticoagulant activity of unfractionated heparin (UFH), however it can cause cardiovascular and respiratory complications. We explored the toxicity of PS and its complexes with UFH in zebrafish, rats, and mice. The involvement of nitric oxide (NO) in the above effects was investigated. Concentration–dependent lethality, morphological defects, and decrease in heart rate (HR) were observed in zebrafish larvae. PS affected HR, blood pressure, respiratory rate, peak exhaled CO2, and blood oxygen saturation in rats. We observed hypotension, increase of HR, perfusion of paw vessels, and enhanced respiratory disturbances with increases doses of PS. We found no effects of PS on human hERG channels or signs of heart damage in mice. The hypotension in rats and bradycardia in zebrafish were partially attenuated by the inhibitor of endothelial NO synthase. The disturbances in cardiovascular and respiratory parameters were reduced or delayed when PS was administered together with UFH. The cardiorespiratory toxicity of PS seems to be charge–dependent and involves enhanced release of NO. PS administered at appropriate doses and ratios with UFH should not cause permanent damage of heart tissue, although careful monitoring of cardiorespiratory parameters is necessary.

15 October 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MZMiłosz Andrzej Zajączkowski
Miłosz Andrzej Zajączkowski
AGAndrej A. Gajić
Andrej A. Gajić
AKAgata Ewa Kaczyńska-Miotk
Agata Ewa Kaczyńska-Miotk
SZStanislaw Zajaczkowski
Stanislaw Zajaczkowski
JKJarosław Kobiela
Jarosław Kobiela
AKAdam Kosiński
Adam Kosiński
To date there is scarce published evidence reporting the dual blood supply reaching anterior papillary muscle (APM), which descends from both major coronary arteries. Such a vascular configuration can prevent the dysfunction of right ventricular entire valvular system in case of the occlusion of proximal part of either right coronary artery (RCA) or left coronary artery (LCA). The aim of our study was to determine the vascular pattern of APM blood supply which originates from two main coronary arteries, in the context of the APM and septomarginal trabecula (SMT) topography. The study was carried out using tissue obtained from 36 human hearts. The material was divided into four morphological types of SMT/APM arrangement. Vascularization and blood supply pattern of papillary muscle was investigated following the analysis of multiple tissue cross sections. The origin of APM arterial supply was traced back to both main coronary arteries. Cross-sectional area of the arteries was estimated at the base of APM and compared within mixed male-female population, aged 18–76. We noted that as much as 78% of entire APM material had a blood supply vasculature originating from both LCA and RCA branches. In contrast, 22% of cases APM was supplied by a single coronary artery, while in each case it proved to be LCA. We have never found APM arterial supply provided exclusively by RCA. In case of double AMP blood supply an average of total cross-section area of the arteries branching from LCA, was noted to be in excess of two and a half times bigger in type III and more than two times bigger in type IV, as compared with the arteries originating from RCA. Our research confirm the possibility of double blood supply which vascularizes APM, but the finding does not necessarily apply in all cases. However, APM seems to be predominantly vascularized by arteries deriving from LCA, regardless of their morphological type.

5 November 2021 in Advances in Clinical and Experimental Medicine
Verified
Journal Article
Open access
AKAgata Ewa Kaczyńska-Miotk
Agata Ewa Kaczyńska-Miotk
AKAdam Kosiński
Adam Kosiński
Katarzyna BobkowskaKatarzyna Bobkowska
Katarzyna Bobkowska
MZMiłosz Zajączkowski
Miłosz Zajączkowski
RKRafał Kamiński
Rafał Kamiński
DKDariusz Kozlowski
Dariusz Kozlowski
The right ventricular outflow tract (RVOT) is located above the supraventricular crest and reaches the level of the pulmonary valve. Detailed knowledge of the RVOT spatial structure and its morphology is extremely important for cardiac invasive therapeutic procedures. To examine the spatial structure of the RVOT using virtual models of the right ventricle (RV) interior obtained post mortem. The study was carried out using 40 adult hearts from both sexes fixed in formalin. Donors had a negative history of cardiovascular diseases. Silicone models of the interior of the RV were made and then subjected to a digital modelling procedure using the photogrammetry technique. For each 3D model of the RV, the RVOT was extracted and measurements were performed. Statistical analysis demonstrated that the dimensions of the transverse (p < 0.001) and sagittal (p = 0.002) axis at the level of the upper and lower border of the RVOT differed significantly. There was also a significant difference between the right and left height of the RVOT (p = 0.009). A clear correlation was found between the volume of the RVOT and the volume of the entire RV (r = 0.718, p < 0.001). The obtained 3D models of the RVOT can help standardize the data related to RVOT architecture. Furthermore, they can extend knowledge about the RVOT in the field of cardiology and improve the procedures in cardiac surgery.

1 January 2018 in European Journal of Translational and Clinical Medicine
Verified
Journal Article
Open access
PDF file
AKAgata Ewa Kaczyńska-Miotk
Agata Ewa Kaczyńska-Miotk
AKAdam Kosiński
Adam Kosiński
RKRafał Kamiński
Rafał Kamiński
MZMiłosz Andrzej Zajączkowski
Miłosz Andrzej Zajączkowski
ENEwa Nowicka
Ewa Nowicka
MGMarta Gleinert-Rożek
Marta Gleinert-Rożek
A novel approach to visualization of the right ventricular outflow tract. Introduction: Nowadays, heart is one of the most demanding organs for imaging procedures. This is related to its irregular shape and complex intern...

15 October 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
MZMiłosz Andrzej Zajączkowski
Miłosz Andrzej Zajączkowski
MDMilena Deptuła-Knioła
Milena Deptuła-Knioła
MZMałgorzata Zawrzykraj-Motylińska
Małgorzata Zawrzykraj-Motylińska
AKAgata Ewa Kaczyńska-Miotk
Agata Ewa Kaczyńska-Miotk
MPMichał Pikuła
Michał Pikuła
AKAdam Kosiński
Adam Kosiński
Cardiovascular diseases remain the leading cause of mortality worldwide and continue to impose a substantial clinical burden despite major advances in pharmacological and interventional therapies. Because the adult myocardium has limited regenerative capacity, irreversible cardiomyocyte loss frequently leads to adverse remodeling and progressive heart failure (HF). Mesenchymal stromal cells (MSCs) are among the most extensively studied cell therapies for cardiac repair because of their immunomodulatory, pro-angiogenic, anti-inflammatory, and anti-fibrotic effects, mediated predominantly through paracrine signaling. This review summarizes the current evidence for MSC-based therapy in ischemic heart disease (IHD), coronary and microvascular disorders, myocardial infarction, HF, myocarditis, pulmonary arterial hypertension, and valvular heart disease (VHD). We discuss MSC sources, preclinical and clinical evidence, manufacturing and dosing, delivery routes, biomaterial-assisted transplantation, preconditioning, genetic modification, and imaging for cell tracking and treatment monitoring. Although MSC therapy has shown a favorable safety profile and regenerative potential, clinical efficacy remains variable because of limited cell survival, poor myocardial retention, and heterogeneous treatment protocols. Further optimization of manufacturing, delivery, and patient selection, together with well-designed randomized trials, is required to establish standardized protocols and support clinical translation.

19 December 2025 in European Journal of Translational and Clinical Medicine
Verified
Journal Article
Open access
PDF file
AKAdam Kosiński
Adam Kosiński
AKAgata Ewa Kaczyńska-Miotk
Agata Ewa Kaczyńska-Miotk
GPGrzegorz Piwko
Grzegorz Piwko
DJDamian Jeżyk
Damian Jeżyk
PSPaulina Słonimska Paulina Słonimska
Paulina Słonimska Paulina Słonimska
MZMiłosz Andrzej Zajączkowski
Miłosz Andrzej Zajączkowski
The length and topographical location of septal papillary muscles in adult human hearts. Background: This study aimed to evaluate the relative length and anatomical position of septal papillary muscles, including the papillary muscle of...